Europe — EMA
Nortriptyline Colonis Pharma
GNH USA supplies Nortriptyline Colonis Pharma (Nortriptyline), a tricyclic antidepressant for major depressive disorder, neuropathic pain, anxiety
Request sourcing
What is Nortriptyline?
Nortriptyline, the active ingredient in Nortriptyline Colonis Pharma, is a tricyclic antidepressant presented as an oral dosage form for oral use. It is used to treat major depressive disorder, neuropathic pain, anxiety disorders, and migraine prophylaxis in adult patients.
GNH USA supplies Nortriptyline Colonis Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Nortriptyline used for?
Nortriptyline is a tricyclic antidepressant that modulates monoamine neurotransmission in several psychiatric and neurological conditions.
- Major depressive disorder: alleviates depressive symptoms and improves mood. - Neuropathic pain: reduces pain intensity in peripheral neuropathy. - Anxiety disorders: lessens anxiety symptoms. - Migraine prophylaxis: decreases the frequency of migraine attacks.
What are the side effects of Nortriptyline?
Nortriptyline may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Dry mouth - Constipation - Drowsiness - Weight gain
Serious or Rare Side Effects: - Cardiac arrhythmias - Seizures - Severe hypotension - Agranulocytosis
What precautions apply to Nortriptyline?
When prescribing nortriptyline, clinicians should consider several safety measures.
- Cardiac monitoring: obtain baseline ECG in patients with known heart disease. - Hepatic assessment: evaluate liver function and adjust dose if impairment is present. - Suicidal ideation: monitor closely during the initial treatment period. - Discontinuation: taper gradually to avoid withdrawal symptoms. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.
What does Nortriptyline interact with?
Nortriptyline interacts with several drug classes that may require avoidance or careful monitoring.
Major Interactions (Avoid): - Monoamine‑oxidase inhibitors: risk of hypertensive crisis. - Other serotonergic agents (SSRIs, SNRIs): potential serotonin syndrome. - Strong CYP2D6 inhibitors (e.g., quinidine): may raise nortriptyline plasma levels.
Moderate Interactions (Monitor Closely): - Anticholinergic drugs: additive dry‑mouth and constipation. - Central nervous system depressants (alcohol, benzodiazepines): enhanced sedation. - Diuretics: increased risk of orthostatic hypotension. - Antihistamines: may potentiate drowsiness.



